1. Home
  2. MYND vs FGEN Comparison

MYND vs FGEN Comparison

Compare MYND & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYND
  • FGEN
  • Stock Information
  • Founded
  • MYND 1998
  • FGEN 1993
  • Country
  • MYND United States
  • FGEN United States
  • Employees
  • MYND 1365
  • FGEN N/A
  • Industry
  • MYND Other Consumer Services
  • FGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYND Real Estate
  • FGEN Health Care
  • Exchange
  • MYND Nasdaq
  • FGEN Nasdaq
  • Market Cap
  • MYND 34.2M
  • FGEN 38.4M
  • IPO Year
  • MYND 2017
  • FGEN 2014
  • Fundamental
  • Price
  • MYND $0.73
  • FGEN $11.58
  • Analyst Decision
  • MYND
  • FGEN Strong Buy
  • Analyst Count
  • MYND 0
  • FGEN 2
  • Target Price
  • MYND N/A
  • FGEN $146.50
  • AVG Volume (30 Days)
  • MYND 135.3K
  • FGEN 52.5K
  • Earning Date
  • MYND 08-27-2025
  • FGEN 11-11-2025
  • Dividend Yield
  • MYND N/A
  • FGEN N/A
  • EPS Growth
  • MYND N/A
  • FGEN N/A
  • EPS
  • MYND N/A
  • FGEN N/A
  • Revenue
  • MYND $209,800,000.00
  • FGEN $7,346,000.00
  • Revenue This Year
  • MYND N/A
  • FGEN N/A
  • Revenue Next Year
  • MYND N/A
  • FGEN N/A
  • P/E Ratio
  • MYND N/A
  • FGEN N/A
  • Revenue Growth
  • MYND N/A
  • FGEN N/A
  • 52 Week Low
  • MYND $0.53
  • FGEN $4.50
  • 52 Week High
  • MYND $3.89
  • FGEN $21.94
  • Technical
  • Relative Strength Index (RSI)
  • MYND 55.71
  • FGEN 60.31
  • Support Level
  • MYND $0.70
  • FGEN $11.12
  • Resistance Level
  • MYND $0.86
  • FGEN $12.53
  • Average True Range (ATR)
  • MYND 0.08
  • FGEN 0.87
  • MACD
  • MYND 0.02
  • FGEN -0.07
  • Stochastic Oscillator
  • MYND 57.36
  • FGEN 69.43

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

Share on Social Networks: